We are still at that point where it would seem we are certainly not able to fund drug through clinic ourselves without another major round of funding. At the same time if we want someone else to provide funding we need to convince them that our platform and its cost to access in royalties etc is well worth their investment. It seems we are certainly doing all we can to draw that interest but still waiting for a nibble. As Ww points out competitors still struggling with naked oligos so surely this is of interest unless they plan to abandon that research? Hard to believe they actually plan to fund clinic themselves but i guess if the rewards of final product are high enough maybe existing major holders would stump up more? Hard to believe they would want to be diluted too heavily after getting this far but hard to keep producing more cash to put in also? Either way its great to see them continually progressing and adding more results. Especially after apparently shaking up some interest from brokers recently.
PYC Price at posting:
4.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)